1. Home
  2. BAOS vs ONCO Comparison

BAOS vs ONCO Comparison

Compare BAOS & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baosheng Media Group Holdings

BAOS

Baosheng Media Group Holdings

HOLD

Current Price

$3.01

Market Cap

3.6M

ML Signal

HOLD

Logo Onconetix Inc.

ONCO

Onconetix Inc.

HOLD

Current Price

$1.48

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAOS
ONCO
Founded
2018
2018
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
4.3M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
BAOS
ONCO
Price
$3.01
$1.48
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
28.7K
142.2K
Earning Date
05-08-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$860,951.00
$1,223,751.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.20
N/A
52 Week Low
$1.52
$1.37
52 Week High
$8.30
$88.40

Technical Indicators

Market Signals
Indicator
BAOS
ONCO
Relative Strength Index (RSI) 56.41 35.31
Support Level $2.78 $1.51
Resistance Level $3.52 $2.30
Average True Range (ATR) 0.25 0.21
MACD 0.04 0.02
Stochastic Oscillator 56.04 0.00

Price Performance

Historical Comparison
BAOS
ONCO

About BAOS Baosheng Media Group Holdings

Baosheng Media Group Holdings Ltd operates as a V-log streaming marketing service provider. The firm offers comprehensive marketing solutions. Its services are Internet effect marketing, V-log or short video streaming marketing including content production and operation, e-commerce marketing, original data platform system service, and AI technology. It provides one-stop and full-link deep customized marketing solutions for partners. Baosheng Group is also a core agency of domestic Internet companies such as Tencent, Alibaba, Bytedance, and Kuaishou, with performing channel marketing services, technologies, and applications.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

Share on Social Networks: